Sage Journals: Discover world-class research

Abstract

Background

Henoch-Schonlein purpura is a systemic small-vessel vasculitis that occurs mainly in children. A review of the literature has suggested a correlation between mean platelet volume and several inflammatory disorders. However, to the best of our knowledge, any potential correlation between mean platelet volume and Henoch-Schonlein purpura has not been reported in the literature. Therefore, our study aimed to evaluate the role of mean platelet volume concentrations in patients with Henoch-Schonlein purpura.

Methods

This study included 97 children with Henoch-Schonlein purpura and 120 healthy individuals as controls.

Results

Mean platelet volume concentrations were found to be significantly lower in Henoch-Schonlein purpura patients compared with healthy controls (8.1 ± 0.86 vs. 9.4 ± 0.81, P < 0.001). Similarly, significant negative correlations were observed between mean platelet volume and neutrophil count, platelet count and erythrocyte sedimentation rate in patients with Henoch-Schonlein purpura (r=−0.327, P = 0.001; r=−0.419, P < 0.001; r=−0.255, P = 0.012). Interestingly, mean platelet volume was significantly lower in the acute phase compared with the convalescent phase of Henoch-Schonlein purpura patients (7.8 ± 0.86 vs. 8.3 ± 0.77, P = 0.002). A cut-off value for mean platelet volume was 7.85 with area under the curve of 0.726 to identify acute phase vs. convalescent phase in patients with Henoch-Schonlein purpura. Mean platelet volume was independently associated with Henoch-Schonlein purpura in logistic regression analysis (odds ratio = 0.114, 95% confidence interval = 0.053–0.243, P < 0.001).

Conclusions

Our results suggest that mean platelet volume is inversely associated with disease in patients with Henoch-Schonlein purpura, and mean platelet volume may be a useful marker to identify active disease in Henoch-Schonlein purpura patients.

Keywords

Henoch-Schonlein purpura mean platelet volume disease activity

Introduction

Henoch-Schonlein purpura (HSP) is a systemic small-vessel vasculitis that mainly occurs in children. The main presenting features are purpura, abdominal pain, arthralgia/arthritis and kidney disease.¹ Although HSP tends to be self-limiting in children, adult patients exhibit severe clinical manifestations.^2,3 Previous studies have shown that high C-reactive protein levels (CRP), leukocytosis, mean platelet volume (MPV), elevated neutrophil–lymphocyte ratio and platelet–lymphocyte ratio are associated with gastrointestinal bleeding in children with HSP.^4–6

MPV reflects the size of platelets and is correlated with platelet function and activation.⁷ In addition, MPV has been considered as an inflammatory biomarker in several diseases, such as tuberculosis, chronic obstructive pulmonary disease, urinary tract infection, severe periodontitis and systemic lupus erythematous.^8–12 However, to the best of our knowledge, there are no studies in the literature on MPV concentrations in childhood HSP activity. Therefore, the aim of this study was to investigate the role of MPV concentrations in patients with HSP.

Patients and methods

This study included 97 HSP children who were admitted to the First Affiliated Hospital of Guangxi Medical University (Nanning, China) from January 2014 to December 2016. Healthy controls consisted of 120 healthy individuals undergoing routine physical examinations at our hospital. Clinical data and laboratory parameters of the patients were collected in electronic medical records at the hospital. The definition of HSP was according to the European League against Rheumatism/Paediatric Rheumatology European Society (EULAR/PRES) diagnostic criteria.¹³ A clinical scoring system was used to identify disease activity in the acute and convalescent phases.^14,15 The acute phase was defined as the period when the patient showed clinical features, including purpura, haematuria, arthralgia, and abdominal pain. However, the convalescent phase was defined as the period during which all HSP symptoms had resolved. Patients with immunologic disorders, hypertension, diabetes, hyperlipidaemia, obesity, acute or chronic infectious disease, chronic renal disease, nephrotic syndrome, inflammatory bowel disease and chronic inflammatory disease were excluded from the study. In addition, patients also were excluded if they had received systemic steroid treatment before the blood count analysis. Platelet count, MPV, haemoglobin, neutrophil count, lymphocyte count, Erythrocyte sedimentation rate (ESR) and CRP were retrospectively collected from the medical records of patients. Routine blood tests were performed using an automatic blood cell analysis instrument (COULTER LH750 Hematology Analyzer, Beckman Coulter, USA).

This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University, and informed consent was obtained from all individuals.

Statistical analyses

Continuous variables are presented as mean ± standard deviation or median (interquartile range), and categorical variables are shown as percentages. The Shapiro-Wilk test was used to evaluate data normality. Continuous variables with a normal distribution were compared using the independent student’s t-test and data that were not normally distributed were analysed by the Mann-Whitney U test. The differences in proportions between two groups were analysed by the Chi-square test. The Spearman approach was used to analyse the correlation between two continuous variables. Receiver operating characteristics (ROC) curve analysis was used to measure the performance of MPV. We used multivariate logistic regression analysis to assess independent parameters associated with HSP. Statistical analysis was performed using SPSS 19.0 software (IBM, USA), and P < 0.05 was considered to be statistically significant.

Results

Demographic characteristics and laboratory data for all individuals are presented in Table 1. There were significant differences between HSP patients and healthy controls in terms of ESR, CRP, haemoglobin and neutrophil count. Interestingly, MPV concentrations were found to be significantly lower in HSP patients than in healthy controls (8.1 ± 0.86 vs. 9.4 ± 0.81, P < 0.001), as shown in Figure 1.

Table 1.

Comparison of demographic and laboratory variables of HSP patients and healthy controls at baseline.

	HSP patients (n = 97)	Healthy controls (n = 120)	P
Gender (male/female; n)	56 /41	79 /41	0.221^a
Age (years)	8.5 ± 3.04	8.2 ± 2.81	0.403^b
Erythrocyte sedimentation rate (mm/h)	19.0 (13.0–32.5)	10.5 (6.0–13.0)	<0.001^c
C-reactive protein (mg/L)	4.9 (2.4–7.1)	2.1 (1.4–2.9)	<0.001^c
Haemoglobin (g/L)	130.4 ± 11.61	134.8 ± 10.76	0.013 ^b
Neutrophil count (10⁹/L)	5.5 ± 2.39	4.2 ± 1.19	<0.001^b
Lymphocyte count (10⁹/L)	2.8 (2.2–4.1)	3.1 (2.5–3.9)	0.110^c
Platelet count (10⁹/L)	309.4 ± 77.83	298.3 ± 75.74	0.292^b
Mean platelet volume (fL)	8.1 ± 0.86	9.4 ± 0.81	<0.001^b

Note: Data are reported as mean ± SD or median (interquartile range).

HSP: Henoch-Schonlein purpura.

Pearson’s chi-square test.

Student’s t-test.

Mann-Whitney U-test.

Figure 1.

Mean platelet volume (MPV) in children with Henoch-Schonlein purpura (HSP) and healthy controls. P < 0.001, Student’s t-test.

The correlation analysis was conducted among MPV and other variables in HSP patients. The results showed that MPV was inversely associated with neutrophil count (r=−0.327, P = 0.001). Similarly, MPV also had a significant negative relationship with platelet count (r=−0.419, P < 0.001) and ESR (r=−0.255, P = 0.012, Figure 2). Moreover, MPV was significantly lower in the acute phase compared with the convalescent phase of HSP patients (7.8 ± 0.86 vs. 8.3 ± 0.77, P = 0.002), as shown in Table 2. In addition, ROC curve analysis was used to identify acute phase vs. convalescent phase in patients with HSP; the sensitivity of 68.5% and specificity of 70.7% for MPV were observed in the study with a cut-off value of 7.85 and area under the curve of 0.726.

Figure 2.

The correlation between mean platelet volume (MPV) and Erythrocyte sedimentation rate (ESR) in children with Henoch-Schonlein purpura (HSP).

Table 2.

Comparison of demographic and laboratory variables in Henoch-Schonlein purpura (HSP) patients with acute and convalescent phase.

	Acute phase (n = 56)	Convalescent phase (n = 41)	P
Gender (male/female; n)	34 /22	22 /19	0.487^a
Age (years)	8.3 ± 3.35	8.9 ± 2.53	0.277^b
Erythrocyte sedimentation rate (mm/h)	28.8 ± 11.32	14.8 ± 9.86	<0.001^b
C-reactive protein (mg/L)	6.2 (4.9–10.2)	2.7 (1.8–4.1)	<0.001^c
Haemoglobin (g/L)	129.4 ± 12.58	131.9 ± 10.11	0.299^b
Neutrophil count (10⁹/L)	5.8 ± 2.35	5.2 ± 2.41	0.163^b
Lymphocyte count (10⁹/L)	2.6 (2.3–4.3)	2.8 (2.1–3.8)	0.753^c
Platelet count (10⁹/L)	319.1 ± 78.29	296.2 ± 76.16	0.154^b
Mean platelet volume (fL)	7.8 ± 0.86	8.3 ± 0.77	0.002 ^b

Note: Data are reported as mean ± SD or median (interquartile range).

Pearson’s chi-square test.

Student’s t-test.

Mann-Whitney U-test.

After adjusting for gender, haemoglobin, platelet count, neutrophil count, CRP and ESR, MPV was associated with HSP in the logistic regression analysis (OR = 0.114, P < 0.001, 95% CI=0.053 to 0.243) (Table 3).

Table 3.

Multivariable analysis between mean platelet volume and patients with Henoch-Schonlein purpura.

Variables	B	SE	P	OR	95% CI
Neutrophil count (10⁹/L)	0.355	0.140	0.011	1.426	1.085–1.874
Erythrocyte sedimentation rate (mm/h)	0.244	0.068	<0.001	1.276	1.117–1.459
Platelet count (10⁹/L)	−0.009	0.004	0.012	0.991	0.984–0.998
Mean platelet volume (fL)	−2.174	0.387	<0.001	0.114	0.053–0.243

OR: odds ratio; 95% CI: 95% confidence interval.

Discussion

In this study, lower MPV values were observed in children with HSP than healthy individuals, and there was a significant inverse correlation with ESR. Interestingly, MPV concentrations were lower in HSP patients in the acute phase when compared with those of patients in the convalescent phase, suggesting a potential role for MPV in monitoring disease activity in HSP patients.

In the past few years, it has been revealed that MPV plays an actual role in inflammatory disorders. Very recently, Lee et al. reported elevated MPV values in children with acute pyelonephritis compared with lower urinary tract infections.¹⁰ Arpaci et al.¹⁶ also demonstrated that MPV concentrations were higher in acromegalic patients. It has been shown that increased MPV is associated with peritonsillar abscess, retinopathy in type 2 diabetes mellitus and rheumatoid arthritis.^17–19 Similarly, increased MPV has been seen in patients with ankylosing spondylitis, hip osteoarthritis and central serous chorioretinopathy.^20–22 Conversely, lower MPV concentrations have been reported in patients with acute mania, acute pancreatitis and venous thromboembolism.^23–25 Moreover, Wang et al. reported a relationship between decreased MPV and severe periodontitis, suggesting that MPV may be a useful inflammatory marker reflecting the periodontal disease.¹¹ These observations indicate that MPV could be regarded as an important marker in assessing several inflammatory diseases. Why are MPV levels low in HSP patients in the acute phase? The answer is not yet clear. However, recent evidence suggests that several inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and interleukin-8 (IL-8), have been found to be increased in HSP patients.^26,27 Further investigation suggests that inflammatory cytokines are closely related to platelet activation in the pathophysiology of diseases and the overproduction of inflammatory cytokines activates megakaryocytes to release more small-sized platelets from the bone marrow into the peripheral blood.²⁸ Even more, there is an evidence that large platelets in high-grade inflammatory diseases are consumed at a greater rate of inflammation sites than small platelets.²⁹ Therefore, a possible explanation for the low MPV concentrations in children with HSP would be that HSP patients with high-grade inflammation may have increased consumption of large platelets.

In the present study, however, several limitations exist. Firstly, it should be noted that this study used only a relatively small sample size, especially of HSP patients between the acute and convalescent phases. Secondly, MPV concentrations in active HSP patients before and after treatment were not evaluated. However, our results suggest that lower MPV concentrations are associated with disease activity in patients with HSP, and therefore, MPV may be a useful marker to identify active disease in HSP patients.

Footnotes

Acknowledgements

We thank MogoEdit for their English editing service.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Ethical approval

The Ethics Committee of the First Affiliated Hospital of Guangxi Medical University approved this study (REC number: 201501005).

Guarantor

WNM.

Contributorship

WCL, LJM and XHL researched literature and conceived the study. WNM was involved in protocol development and gaining ethical approval, YZL and LQQ collected the data. ZY performed data analysis and XS wrote the first draft of the manuscript. All authors reviewed and edited the manuscript and approved the final version of the manuscript.

References

McCarthy

Tizard

. Clinical practice: diagnosis and management of Henoch-Schonlein purpura. Eur J Pediatr 2010; 169: 643–650.

Pillebout

Thervet

Hill

et al.

Henoch-Schonlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002; 13: 1271–1278.

Kang

Park

. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schonlein purpura. J Korean Med Sci 2014; 29: 198–203.

Lin

Huang

Hsieh

. Clinical and laboratory correlation of acute Henoch-Schonlein purpura in children. Zhonghua Minguo xiao er ke yi xue hui za zhi 1998; 39: 94–98.

Makay

Gucenmez

Duman

et al.

The relationship of neutrophil-to-lymphocyte ratio with gastrointestinal bleeding in Henoch-Schonlein purpura. Rheumatol Int 2014; 34: 1323–1327.

Gayret

Erol

Tekin Nacaroglu

. The relationship of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio with gastrointestinal bleeding in Henoch-Schonlein purpura. Iran J Pediatr 2016; 26: e8191–e8191.

Bath

Butterworth

. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157–161.

Lee

Kim

Lee

et al.

Mean platelet volume in mycobacterium tuberculosis infection. Biomed Res Int 2016; 2016: 7508763–7508763.

Agapakis

Massa

Hantzis

et al.

The role of mean platelet volume in chronic obstructive pulmonary disease exacerbation. Respir Care 2016; 61: 44–49.

10.

Lee

Shin

Park

et al.

Mean platelet volume in young children with urinary tract infection. Sci Rep 2015; 5: 18072–18072.

11.

Wang

Meng

et al.

Mean platelet volume as an inflammatory marker in patients with severe periodontitis. Platelets 2015; 26: 67–71.

12.

Khan

Haider

Ayub

et al.

Mean platelet volume (MPV) as an indicator of disease activity and severity in lupus. F1000Res 2017; 6: 126–126.

13.

Ozen

Ruperto

Dillon

et al.

EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006; 65: 936–941.

14.

De Mattia

Penza

Giordano

et al.

von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura. Pediatr Nephrol 1995; 9: 603–605.

15.

Yilmaz

Kavakli

Ozkayin

. The elevated markers of hypercoagulability in children with Henoch-Schonlein purpura. Pediatr Hematol Oncol 2005; 22: 41–48.

16.

Arpaci

Kuzu

Unal

et al.

Assessment of mean platelet volume and its effect on disease control in patients with acromegaly. Clin Lab 2016; 62: 2167–2171.

17.

Senturk

Azgin

Ovet

et al.

The role of the mean platelet volume and neutrophil-to-lymphocyte ratio in peritonsillar abscesses. Braz J Otorhinolaryngol 2016; 82: 662–667.

18.

Gungor

Gursoy

Gungor

et al.

The relationship of mean platelet volume with retinopathy in type 2 diabetes mellitus. Turkish J Med Sci 2016; 46: 1292–1299.

19.

Talukdar

Barui

Adhikari

et al.

A study on association between common haematological parameters and disease activity in rheumatoid arthritis. J Clin Diagn Res 2017; 11: Ec01–Ec04.

20.

Sezgin

Tecer

Kanik

et al.

Serum RDW and MPV in ankylosing spondylitis: can they show the disease activity?

Clin Hemorheol Microcirc 2017; 65: 1–10.

21.

Tasoglu

Sahin

Karatas

et al.

Blood mean platelet volume and platelet lymphocyte ratio as new predictors of hip osteoarthritis severity. Medicine 2017; 96: e6073–e6073.

22.

Dursun

Toker

Ozec

et al.

Relationship between mean platelet volume and central serous chorioretinopathy. Int Ophthalmol 2017; 37: 119–124.

23.

Mayda

Ahsen

Bagcioglu

et al.

Effect of increased neutrophil-to-lymphocyte ratio (NLR) and decreased mean platelet volume (MPV) values on inflammation in acute mania. Noro Psikiyatri Arsivi 2016; 53: 317–320.

24.

Lei

Zhou

Liu

et al.

Can mean platelet volume play a role in evaluating the severity of acute pancreatitis?

World J Gastroenterol 2017; 23: 2404–2413.

25.

Lippi

Buonocore

Cervellin

. The mean platelet volume is decreased in patients diagnosed with venous thromboembolism in the emergency department. Semin Thromb Hemostasis 2016; 42: 632–635.

26.

. The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura. Pediatr Nephrology 2005; 20: 149–153.

27.

Kimura

Takeuchi

Soma

et al.

Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch-Schonlein purpura. Clin Exp Dermatol 2013; 38: 730–736.

28.

Gasparyan

Ayvazyan

Mikhailidis

et al.

Mean platelet volume: a link between thrombosis and inflammation?

Curr Pharma Des 2011; 17: 47–58.

29.

Gasparyan

Sandoo

Stavropoulos-Kalinoglou

et al.

Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy. Rheumatol Int 2010; 30: 1125–1129.

Altered mean platelet volume in children with Henoch-Schonlein purpura and its association with disease activity

Abstract

Background

Methods

Results

Conclusions

Keywords

Introduction

Patients and methods

Statistical analyses

Results

Discussion

Footnotes

Acknowledgements

Declaration of conflicting interests

Funding

Ethical approval

Guarantor

Contributorship

References